Excalipoint Therapeutics
Latest round
- Seed
Last raised
- Feb 2026
Total raised
- $69M
Investors
- 11
About Excalipoint Therapeutics
Excalipoint Therapeutics, Inc.Founded in 2026, Excalipoint Therapeutics, Inc. specializes in biotechnology aimed at developing therapeutics for cancer and autoimmune diseases. The company has conducted a total of 2 deals.Excalipoint Therapeutics, Inc. specializes in biotechnological products aimed at addressing specific health and wellness challenges. The company’s core offerings include a variety of innovative biological solutions designed for clinical applications, including diagnostics and therapeutic treatments. These products are engineered to enhance patient outcomes through advanced biomolecular technologies, primarily serving healthcare providers and institutions.The revenue structure of Excalipoint Therapeutics, Inc. is based on direct sales to healthcare providers and institutions, characterized by B2B transactions that focus on delivering tailored solutions. The company collaborates with distributors and wholesalers to expand its reach in both domestic and international markets.In February 2026, Excalipoint Therapeutics, Inc. The company plans to launch new products aimed at these health challenges and expand its market reach into additional geographic regions by the end of 2026.
Who invested in Excalipoint Therapeutics
11 investors across 2 rounds
See all investors in Excalipoint Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Excalipoint Therapeutics
Who invested in Excalipoint Therapeutics?
Excalipoint Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Excalipoint Therapeutics raised?
Excalipoint Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Excalipoint Therapeutics last raise money?
Excalipoint Therapeutics's most recent round on record is a Seed, in Feb 2026.
What does Excalipoint Therapeutics do?
Excalipoint Therapeutics is a biotechnology company.
Where is Excalipoint Therapeutics headquartered?
Excalipoint Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Excalipoint Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Excalipoint Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Excalipoint Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.